GSK-204685

Study Sponsor: GSK

Study Title

A 2-part randomized, double-blind (sponsor-unblinded), placebo-controlled, ascending dose and parallel group study of TLR4 agonist (GSK1795091) administered to healthy subjects

Medicine or Vaccine (generic name)

GSK1795091

Sponsor Identification Number

204685

Trial Registry Identification Number(#'s)

NCT02798978 2016-000759-28

Medical Condition

Neoplasms

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204685

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02798978

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-000759-28

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

September 2020